Acting as a bridge between Scripps Health and The Scripps Research Institute , the Scripps Translational Science Institute (STSI) works to translate the latest advances in genomics into new diagnostics and treatments. Our main focus is extending “health span,” so that advancing age does not mean poor health.
In collaboration with Scripps Genomic Medicine , STSI researchers have collected DNA to generate a comprehensive human DNA bank. These samples could help identify genetic markers for cardiovascular disease, breast, colon and prostate cancers and other conditions.
STSI and Scripps Genomic Medicine investigators have also partnered with Affymetrix, Microsoft and Navigenics to determine whether personal genomic testing motivates people to make positive lifestyle changes.
In the Wellderly Study, investigators are collecting DNA from more than 1,000 healthy elderly patients (80+ years of age) with no history of chronic illness. By genotyping and sequencing these remarkable individuals, researchers hope to identify the genomic mechanisms that promote health span.
For more information on current research at Scripps, visit the active studies page.